With two somewhat provocative Power Lists behind us, we once again forge ahead with our mission to celebrate the fantastic individuals involved in bettering the pharma industry, and in bringing life-changing medicines to market. Welcome to the 2017 Power List, where we delve into the passions, pivotal moments and predictions of the Top 100 most influential people in the drug development industry divided into four categories – each made up of 25 names and led with a Top 10: Masters of the Bench, Industry Influencers, Business Captains, and Champions of Change.
False
False
Recommended
False
Related Content
The Biggest Bottlenecks Holding Back Cell and Gene Therapy
August 24, 2026
9 min read
Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges
Musings from The Power List: Daniel Vitt
August 20, 2026
6 min read
From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development
The Road to Commercial-Scale iPSC Cell Therapy
August 19, 2026
5 min read
Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?
The Mindset for Success in Biopharma's New Multipolar World
August 18, 2026
10 min read
From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market
